Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Chronic inflammatory demyelinating polyneuropathy associated with alopecia totalis and Sjögren syndrome.
Murine therapeutic models for Charcot-Marie-Tooth (CMT) disease.
Mechanisms and time course of neuronal degeneration in experimental autoimmune encephalomyelitis.
Lung inflammation stalls Th17 cell migration en route to the central nervous system during the development of experimental autoimmune encephalomyelitis.
Immunomodulation by vitamin D in multiple sclerosis: More than IL-17.
CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells.
Human myelin proteome and comparative analysis with mouse myelin.
A systematic methodology for large scale compound screening: A case study on the discovery of novel S1PL inhibitors.
Pediatric idiopathic transverse myelitis presenting as an anterior cord syndrome: A case report.
Disease activity return after natalizumab cessation in multiple sclerosis.
Deficiency of NF-kappaB c-Rel Accelerates the Development of Autoimmune Diabetes in Non-Obese Diabetic Mice.
Daily fingolimod administration may cause lymphopenia but alternate-day administration may be too little to inhibit disease activity.
Multiple Sclerosis.
Seroprevalence of NMO-IgG among patients with neuromyelitis optica and opticospinal multiple sclerosis.
What you cannot get from routine MRI of MS patient and why - The growing need for atrophy assessment and seeing beyond the plaque.
[Pathology, diagnosis, and treatment of combined central and peripheral demyelination].
High immunogenicity of intracellular myelin oligodendrocyte glycoprotein epitopes.
Vitamin D in the healthy and inflamed central nervous system: access and function.
Good cardiac safety in patients with relapsing remitting multiple sclerosis upon first fingolimod dose.
Tracking CNS and systemic sources of oxidative stress during the course of chronic neuroinflammation.
Neuromyelitis optica (NMO) and autoimmune thyroiditis.
Pre-Existing Mature Oligodendrocytes Do Not Contribute to Remyelination following Toxin-Induced Spinal Cord Demyelination.
Modeling The Natural History of Secondary-Progressive Multiple Sclerosis: A New Modeling Approach Using Discrete Event Simulation.
Comparison of Network Meta-Analysis and Traditional Meta-Analysis for Prevention of Relapses In Multiple Sclerosis.
Impaired oligodendrocyte maturation in preterm infants: Potential therapeutic targets.
Pages
« first
‹ previous
…
719
720
721
722
723
724
725
726
727
…
next ›
last »